Treatment With Romosozumab Versus Denosumab to Improve Bone Mineral Density and Architecture in Subacute SCI
Latest Information Update: 07 Mar 2024
At a glance
- Drugs Denosumab (Primary) ; Romosozumab (Primary)
- Indications Osteoporosis; Spinal cord injuries
- Focus Therapeutic Use
- 29 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 05 Nov 2021 New trial record